Trial intelligence / Profile preview

Blood Transfusion and Oxidative Stress in Neonates

NCT03767361Phase 1Completed

Start
Jun 2018
Primary completion
Nov 2019
Modality
Recombinant Proteins and Enzymes, Cell Therapies
Countries
1
01

Overview

Phase 1, randomised trial of red blood cells in anemia of prematurity (AOP). Primary endpoints: malondialdehyde, total antioxidant capacity and 1 more. Started Jun 2018; status: completed.

02

Drugs

red blood cells
03

Conditions

anemia of prematurity (AOP)

Beyond the preview

Go deeper on NCT03767361.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03767361.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call